# The Chinese-made Praziquantel for Treatment of Schistosoma Haematobium

> **NCT03133832** · PHASE3 · UNKNOWN · sponsor: **Jiangsu Institute of Parasitic Diseases** · enrollment: 120 (estimated)

## Conditions studied

- Schistosomiasis Haematobia

## Interventions

- **DRUG:** Companion Tablet

## Key facts

- **NCT ID:** NCT03133832
- **Lead sponsor:** Jiangsu Institute of Parasitic Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-10
- **Primary completion:** 2017-06-30
- **Final completion:** 2017-07-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03133832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03133832, "The Chinese-made Praziquantel for Treatment of Schistosoma Haematobium". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03133832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*